{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T16:51:55Z","timestamp":1787503915802,"version":"build-2736575974"},"reference-count":90,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,1,14]],"date-time":"2025-01-14T00:00:00Z","timestamp":1736812800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>The non-polio Enteroviruses (NPEVs), consist of enteroviruses, coxsackieviruses, echoviruses, and rhinoviruses, are causative agents for a wide variety of diseases, ranging from common cold to encephalitis and acute flaccid paralysis (AFP). In recent years, several NPEVs have become serious public health threats, include EV-A71, which has caused epidemics of hand-foot-and-mouth disease (HMFD) in Southeast Asia, and EV-D68, which caused outbreaks of severe respiratory disease in children worldwide. Infections with these viruses are associated with neurological diseases like aseptic meningitis and AFP. Currently, apart from inactivated EV-A71 vaccines that were developed in China, no effective measures are available to prevent or treat NPEV infections. Antibody-mediated immunity is crucial for preventing and limiting viral infections, and potent neutralizing antibodies could serve as potential therapeutic agents. In this review, we describe recent progress in the NPEVs neutralization antibodies, summarizing the characteristics, breadth, and potency against NPEVs, such as EV-A71, CVA16, EV-D68, and echovirus. We focus on not only through the study of viral epitopes but also through the understanding of virus-antibody interactions. Also, we decipher the role of antibodies in the attachment of the virus to receptors, internalization, and uncoating process, providing insight into virus neutralization mechanisms. Moreover, bi-specific antibodies or multivalent antibodies with better potency are also discussed. Therefore, an in-depth understanding of structures of enterovirus and mechanisms of antibody neutralization should be useful for future strategies in guiding the design of a rational antiviral agent against NPEVs infections.<\/jats:p>","DOI":"10.3389\/fimmu.2024.1524356","type":"journal-article","created":{"date-parts":[[2025,1,14]],"date-time":"2025-01-14T00:12:15Z","timestamp":1736813535000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["Neutralizing antibody landscape of the non-polio Enteroviruses and future strategy"],"prefix":"10.3389","volume":"15","author":[{"given":"Hongye","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenbing","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,1,14]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1097\/QCO.0000000000000187","article-title":"The epidemiology of non-polio enteroviruses: recent advances and outstanding questions","volume":"28","author":"Pons-Salort","year":"2015","journal-title":"Curr Opin Infect Dis"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms8121856","article-title":"Epidemiology and sequence-based evolutionary analysis of circulating non-polio enteroviruses","volume":"8","author":"Brown","year":"2020","journal-title":"Microorganisms"},{"key":"B3","doi-asserted-by":"publisher","first-page":"4","DOI":"10.7774\/cevr.2017.6.1.4","article-title":"Enterovirus 71 infection and vaccines","volume":"6","author":"Yi","year":"2017","journal-title":"Clin Exp Vaccine Res"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1136\/jech-2014-203836","article-title":"Enterovirus 71 related severe hand, foot and mouth disease outbreaks in South-East Asia: current situation and ongoing challenges","volume":"68","author":"Sabanathan","year":"2014","journal-title":"J Epidemiol Community Health"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)62457-0","article-title":"A cluster of acute flaccid paralysis and cranial nerve dysfunction temporally associated with an outbreak of enterovirus D68 in children in Colorado, USA","volume":"385","author":"Messacar","year":"2015","journal-title":"Lancet"},{"key":"B6","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1097\/INF.0000000000002889","article-title":"Outbreak of enterovirus D68 among children in Japan-worldwide circulation of enterovirus D68 clade B3 in 2018","volume":"40","author":"Ikuse","year":"2021","journal-title":"Pediatr Infect Dis J"},{"key":"B7","doi-asserted-by":"publisher","first-page":"105618","DOI":"10.1016\/j.jcv.2023.105618","article-title":"Clinical and molecular characteristics of the 2022 Enterovirus-D68 outbreak among hospitalized children, Ohio, USA","volume":"169","author":"Cao","year":"2023","journal-title":"J Clin Virol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3201\/eid2906.221795","article-title":"Enterovirus D68 outbreak in children, Finland, August-September 2022","volume":"29","author":"Peltola","year":"2023","journal-title":"Emerg Infect Dis"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1159\/000489339","article-title":"Coxsackievirus A24 variant associated with acute haemorrhagic conjunctivitis cases, French Guiana, 2017","volume":"60","author":"Enfissi","year":"2017","journal-title":"Intervirology"},{"key":"B10","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1186\/s13104-017-3007-9","article-title":"An outbreak of acute haemorrhagic conjunctivitis associated with coxsackievirus A24 variant in The Gambia, West Africa","volume":"10","author":"Burr","year":"2017","journal-title":"BMC Res Notes"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1007\/s00705-019-04520-6","article-title":"Recommendations for the nomenclature of enteroviruses and rhinoviruses","volume":"165","author":"Simmonds","year":"2020","journal-title":"Arch Virol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0000000000001242","article-title":"The epidemiology of hand, foot and mouth disease in Asia: a systematic review and analysis","volume":"35","author":"Koh","year":"2016","journal-title":"Pediatr Infect Dis J"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3390\/v7122947","article-title":"Epidemiological research on hand, foot, and mouth disease in mainland China","volume":"7","author":"Zhuang","year":"2015","journal-title":"Viruses"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.clindermatol.2014.12.011","article-title":"Update on hand-foot-and-mouth disease","volume":"33","author":"Ventarola","year":"2015","journal-title":"Clinics Dermatol"},{"key":"B15","article-title":"Hand-foot-and-mouth disease: rapid evidence review","volume":"100","author":"Saguil","year":"2019","journal-title":"Am Fam Physician"},{"key":"B16","article-title":"Hand-foot-and-mouth disease caused by coxsackievirus A6 on the rise","volume":"102","author":"Kimmis","year":"2018","journal-title":"Cutis"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa1853","article-title":"Basic reproduction number of enterovirus 71 and coxsackievirus A16 and A6: evidence from outbreaks of hand, foot, and mouth disease in China between 2011 and 2018","volume":"73","author":"Zhang","year":"2021","journal-title":"Clin Infect Dis"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1007\/s11262-014-1152-y","article-title":"Recombination among human non-polio enteroviruses: implications for epidemiology and evolution","volume":"50","author":"Kyriakopoulou","year":"2015","journal-title":"Virus Genes"},{"key":"B19","doi-asserted-by":"publisher","first-page":"199","DOI":"10.3390\/vaccines9030199","article-title":"Enterovirus A71 vaccines","volume":"9","author":"Li","year":"2021","journal-title":"Vaccines (Basel)"},{"key":"B20","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s12929-019-0560-7","article-title":"Antivirals and vaccines for enterovirus A71","volume":"26","author":"Lin","year":"2019","journal-title":"J BioMed Sci"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3390\/v7122949","article-title":"Recent progress towards novel EV71 anti-therapeutics and vaccines","volume":"7","author":"Ng","year":"2015","journal-title":"Viruses"},{"key":"B22","doi-asserted-by":"publisher","first-page":"2340854","DOI":"10.1080\/21645515.2024.2340854","article-title":"The need for development of other enterovirus vaccines in addition to EV-A71 vaccine","volume":"20","author":"Xu","year":"2024","journal-title":"Hum Vaccin Immunother"},{"key":"B23","doi-asserted-by":"publisher","first-page":"169","DOI":"10.3390\/ijms24010169","article-title":"Hand-foot-and-mouth disease-associated enterovirus and the development of multivalent HFMD vaccines","volume":"24","author":"Zhang","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B24","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s12929-023-00908-4","article-title":"Current status of hand-foot-and-mouth disease","volume":"30","author":"Zhu","year":"2023","journal-title":"J BioMed Sci"},{"key":"B25","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1080\/17460441.2021.1965987","article-title":"Novel strategies for the development of hand, foot, and mouth disease vaccines and antiviral therapies","volume":"17","author":"Fang","year":"2022","journal-title":"Expert Opin Drug Discovery"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2020.10.002","article-title":"Neutralizing antibody against Enterovirus-A71 in Thai children: A longitudinal study from birth to age 4 years","volume":"38","author":"Puenpa","year":"2020","journal-title":"Vaccine"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.3201\/eid2503.180960","article-title":"Neutralizing Antibody against Enterovirus D68 in Children and Adults before 2014 Outbreak, Kansas City, Missouri, USA(1)","volume":"25","author":"Harrison","year":"2019","journal-title":"Emerg Infect Dis"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.02226-12","article-title":"Enterovirus 71 uses cell surface heparan sulfate glycosaminoglycan as an attachment receptor","volume":"87","author":"Tan","year":"2013","journal-title":"J Virol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.virol.2016.11.009","article-title":"VP1 residues around the five-fold axis of enterovirus A71 mediate heparan sulfate interaction","volume":"501","author":"Tan","year":"2017","journal-title":"Virology"},{"key":"B30","doi-asserted-by":"publisher","first-page":"e1002826","DOI":"10.1371\/journal.ppat.1002826","article-title":"Identification of site-specific adaptations conferring increased neural cell tropism during human enterovirus 71 infection","volume":"8","author":"Cordey","year":"2012","journal-title":"PloS Pathog"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1038\/nm.1961","article-title":"Human P-selectin glycoprotein ligand-1 is a functional receptor for enterovirus 71","volume":"15","author":"Nishimura","year":"2009","journal-title":"Nat Med"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00573-13","article-title":"Caveolar endocytosis is required for human PSGL-1-mediated enterovirus 71 infection","volume":"87","author":"Lin","year":"2013","journal-title":"J Virol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1003511","article-title":"Enterovirus 71 binding to PSGL-1 on leukocytes: VP1-145 acts as a molecular switch to control receptor interaction","volume":"9","author":"Nishimura","year":"2013","journal-title":"PloS Pathog"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00020-12","article-title":"Human SCARB2-dependent infection by coxsackievirus A7, A14, and A16 and enterovirus 71","volume":"86","author":"Yamayoshi","year":"2012","journal-title":"J Virol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1038\/nm.1992","article-title":"Scavenger receptor B2 is a cellular receptor for enterovirus 71","volume":"15","author":"Yamayoshi","year":"2009","journal-title":"Nat Med"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12929-020-0615-9","article-title":"Cellular receptors for enterovirus A71","volume":"27","author":"Kobayashi","year":"2020","journal-title":"J Biomed Sci"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.02358-10","article-title":"Identification of a human SCARB2 region that is important for enterovirus 71 binding and infection","volume":"85","author":"Yamayoshi","year":"2011","journal-title":"J Virol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01926-13","article-title":"A strain-specific epitope of enterovirus 71 identified by cryo-electron microscopy of the complex with fab from neutralizing antibody","volume":"87","author":"Lee","year":"2013","journal-title":"J Virol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"498","DOI":"10.7150\/thno.7457","article-title":"Protection against Lethal Enterovirus 71 Challenge in Mice by a Recombinant Vaccine Candidate Containing a Broadly Cross-Neutralizing Epitope within the VP2 EF Loop","volume":"4","author":"Xu","year":"2014","journal-title":"Theranostics"},{"key":"B40","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1007\/s13238-017-0405-7","article-title":"The binding of a monoclonal antibody to the apical region of SCARB2 blocks EV71 infection","volume":"8","author":"Zhang","year":"2017","journal-title":"Protein Cell"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1038\/s41564-018-0319-z","article-title":"Unexpected mode of engagement between enterovirus 71 and its receptor SCARB2","volume":"4","author":"Zhou","year":"2019","journal-title":"Nat Microbiol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.01013-18","article-title":"Neutralization mechanisms of two highly potent antibodies against human enterovirus 71","volume":"9","author":"Zhu","year":"2018","journal-title":"mBio"},{"key":"B43","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1320624111","article-title":"Neutralizing antibodies can initiate genome release from human enterovirus 71","volume":"111","author":"Plevka","year":"2014","journal-title":"Proc Natl Acad Sci U.S.A"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1016\/j.jviromet.2012.06.025","article-title":"Development of murine monoclonal antibodies with potent neutralization effects on enterovirus 71","volume":"186","author":"Ku","year":"2012","journal-title":"J Virol Methods"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.02189-15","article-title":"Single Neutralizing Monoclonal Antibodies Targeting the VP1 GH Loop of Enterovirus 71 Inhibit both Virus Attachment and Internalization during Viral Entry","volume":"89","author":"Ku","year":"2015","journal-title":"J Virol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1005454","article-title":"Structural basis for recognition of human enterovirus 71 by a bivalent broadly neutralizing monoclonal antibody","volume":"12","author":"Ye","year":"2016","journal-title":"PloS Pathog"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1016\/j.virusres.2006.12.005","article-title":"Identification of neutralizing linear epitopes from the VP1 capsid protein of Enterovirus 71 using synthetic peptides","volume":"125","author":"Foo","year":"2007","journal-title":"Virus Res"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2011.04.010","article-title":"Identification and characterization of a cross-neutralization epitope of Enterovirus 71","volume":"29","author":"Liu","year":"2011","journal-title":"Vaccine"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00682-18","article-title":"VP1 amino acid residue 145 of enterovirus 71 is a key residue for its receptor attachment and resistance to neutralizing antibody during cynomolgus monkey infection","volume":"92","author":"Fujii","year":"2018","journal-title":"J Virol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0002895","article-title":"A novel universal neutralizing monoclonal antibody against enterovirus 71 that targets the highly conserved \u201cKnob\u201d Region of VP3 protein","volume":"8","author":"Kiener","year":"2014","journal-title":"PloS Negl Trop Dis"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1128\/mbio.03660-21","article-title":"Cross-reactive antibody responses against nonpoliovirus enteroviruses","volume":"13","author":"Rosenfeld","year":"2022","journal-title":"Mbio"},{"key":"B52","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.coviro.2021.10.006","article-title":"Structural basis for neutralization of enterovirus","volume":"51","author":"Huang","year":"2021","journal-title":"Curr Opin Virol"},{"key":"B53","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1038\/s41467-017-00736-9","article-title":"Epitope-associated and specificity-focused features of EV71-neutralizing antibody repertoires from plasmablasts of infected children","volume":"8","author":"Arthur Huang","year":"2017","journal-title":"Nat Commun"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0079599","article-title":"The cross-neutralizing activity of enterovirus 71 subgenotype c4 vaccines in healthy chinese infants and children","volume":"8","author":"Mao","year":"2013","journal-title":"PloS One"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2020.562768","article-title":"Human antibodies to VP4 inhibit replication of enteroviruses across subgenotypes and serotypes, and enhance host innate immunity","author":"Phanthong","year":"2020","journal-title":"Front Microbiol"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0029751","article-title":"Characterization of an isotype-dependent monoclonal antibody against linear neutralizing epitope effective for prophylaxis of enterovirus 71 infection","volume":"7","author":"Lim","year":"2012","journal-title":"PloS One"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1007\/s00253-015-6652-8","article-title":"Generation and characterization of a protective mouse monoclonal antibody against human enterovirus 71","volume":"99","author":"Deng","year":"2015","journal-title":"Appl Microbiol Biotechnol"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2021.09.056","article-title":"A broad and potent IgM antibody against tetra-EV-As induced by EVA71 and CVA16 co-immunization","volume":"39","author":"Zhu","year":"2021","journal-title":"Vaccine"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01922-19","article-title":"Antiviral activity of a llama-derived single-domain antibody against enterovirus A71","volume":"64","author":"Huang","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"key":"B60","doi-asserted-by":"publisher","first-page":"100860","DOI":"10.1016\/j.bbrep.2020.100860","article-title":"Engineering a novel IgG-like bispecific antibody against enterovirus A71","volume":"24","author":"Wang","year":"2020","journal-title":"Biochem Biophys Rep"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aat7459","article-title":"Discovery and structural characterization of a therapeutic antibody against coxsackievirus A10","volume":"4","author":"Zhu","year":"2018","journal-title":"Sci Adv"},{"key":"B62","doi-asserted-by":"publisher","first-page":"114298","DOI":"10.1016\/j.jviromet.2021.114298","article-title":"Preparation and verification of a monoclonal antibody against a conserved linear epitope in enterovirus A protein 2C","volume":"298","author":"Liu","year":"2021","journal-title":"J Virol Methods"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2019.1565266","article-title":"A potential therapeutic neutralization monoclonal antibody specifically against multi-coxsackievirus A16 strains challenge","volume":"15","author":"Du","year":"2019","journal-title":"Hum Vaccin Immunother"},{"key":"B64","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.chom.2020.01.003","article-title":"Identification of antibodies with non-overlapping neutralization sites that target coxsackievirus A16","volume":"27","author":"He","year":"2020","journal-title":"Cell Host Microbe"},{"key":"B65","doi-asserted-by":"publisher","first-page":"4419","DOI":"10.1038\/s41467-020-18250-w","article-title":"Serotype specific epitopes identified by neutralizing antibodies underpin immunogenic differences in Enterovirus B","volume":"11","author":"Wang","year":"2020","journal-title":"Nat Commun"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1800655","article-title":"A novel neutralizing antibody specific to the DE loop of VP1 can inhibit EV-D68 infection in mice","volume":"201","author":"Zheng","year":"2018","journal-title":"J Immunol"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1038\/s41564-018-0275-7","article-title":"Atomic structures of enterovirus D68 in complex with two monoclonal antibodies define distinct mechanisms of viral neutralization","volume":"4","author":"Zheng","year":"2019","journal-title":"Nat Microbiol"},{"key":"B68","doi-asserted-by":"publisher","first-page":"2904","DOI":"10.1038\/s41467-021-23199-5","article-title":"Functional and structural characterization of a two-MAb cocktail for delayed treatment of enterovirus D68 infections","volume":"12","author":"Zhang","year":"2021","journal-title":"Nat Commun"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.aba4902","article-title":"Human antibodies neutralize enterovirus D68 and protect against infection and paralytic disease","volume":"5","author":"Vogt","year":"2020","journal-title":"Sci Immunol"},{"key":"B70","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1707369114","article-title":"Antibody-induced uncoating of human rhinovirus B14","volume":"114","author":"Dong","year":"2017","journal-title":"Proc Natl Acad Sci U.S.A"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1707369114","article-title":"Prevention of cell death by antibodies selected from intracellular combinatorial libraries","volume":"21","author":"Xie","year":"2014","journal-title":"Chem Biol"},{"key":"B72","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1016\/j.chom.2018.03.019","article-title":"KREMEN1 is a host entry receptor for a major group of enteroviruses","volume":"23","author":"Staring","year":"2018","journal-title":"Cell Host Microbe"},{"key":"B73","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.antiviral.2014.02.015","article-title":"A murine model of coxsackievirus A16 infection for anti-viral evaluation","volume":"105","author":"Liu","year":"2014","journal-title":"Antiviral Res"},{"key":"B74","doi-asserted-by":"publisher","first-page":"66","DOI":"10.7883\/yoken.JJID.2015.060","article-title":"Phage display-derived cross-reactive neutralizing antibody against enterovirus 71 and coxsackievirus A16","volume":"69","author":"Zhang","year":"2016","journal-title":"Jpn J Infect Dis"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2013.02.051","article-title":"Identification of conserved neutralizing linear epitopes within the VP1 protein of coxsackievirus A16","volume":"31","author":"Shi","year":"2013","journal-title":"Vaccine"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.3201\/eid2706.203096","article-title":"Molecular epidemiology and evolutionary trajectory of emerging echovirus 30, Europe","volume":"27","author":"Benschop","year":"2021","journal-title":"Emerg Infect Dis"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES.2018.23.44.1800537","article-title":"Upsurge in echovirus 30 detections in five EU\/EEA countries, April to September, 2018","volume":"23","author":"Broberg","year":"2018","journal-title":"Euro Surveill"},{"key":"B78","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/s41598-017-18495-4","article-title":"A novel rat CVB1-VP1 monoclonal antibody 3A6 detects a broad range of enteroviruses","volume":"8","author":"Saarinen","year":"2018","journal-title":"Sci Rep"},{"key":"B79","article-title":"Clusters of acute respiratory illness associated with human enterovirus 68\u2013Asia, Europe, and United States, 2008-2010","volume":"60","year":"2011","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(15)00335-5","article-title":"Severe respiratory illness associated with a nationwide outbreak of enterovirus D68 in the USA (2014): a descriptive epidemiological investigation","volume":"3","author":"Midgley","year":"2015","journal-title":"Lancet Respir Med"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2018.12.012","article-title":"Rhinoviruses and their receptors","volume":"155","author":"Basnet","year":"2019","journal-title":"Chest"},{"key":"B82","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.antiviral.2018.11.001","article-title":"A bispecific broadly neutralizing antibody against enterovirus 71 and coxsackievirus A16 with therapeutic potential","volume":"161","author":"Zhou","year":"2019","journal-title":"Antiviral Res"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1918844117","article-title":"Inhibitory antibodies identify unique sites of therapeutic vulnerability in rhinovirus and other enteroviruses","volume":"117","author":"Meng","year":"2020","journal-title":"Proc Natl Acad Sci U.S.A"},{"key":"B84","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.jviromet.2018.02.001","article-title":"New Coxsackievirus 2A(pro) and 3C(pro) protease antibodies for virus detection and discovery of pathogenic mechanisms","volume":"255","author":"Laitinen","year":"2018","journal-title":"J Virol Methods"},{"key":"B85","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1038\/s41467-017-00477-9","article-title":"Atomic structures of Coxsackievirus A6 and its complex with a neutralizing antibody","volume":"8","author":"Xu","year":"2017","journal-title":"Nat Commun"},{"key":"B86","doi-asserted-by":"publisher","first-page":"360","DOI":"10.3390\/v13030360","article-title":"Mechanisms of rhinovirus neutralisation by antibodies","volume":"13","author":"Touabi","year":"2021","journal-title":"Viruses"},{"key":"B87","doi-asserted-by":"publisher","first-page":"46402","DOI":"10.1038\/srep46402","article-title":"Effective in vivo therapeutic IgG antibody against VP3 of enterovirus 71 with receptor-competing activity","volume":"7","author":"Jia","year":"2017","journal-title":"Sci Rep"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-022-04797-9","article-title":"Combination anti-HIV antibodies provide sustained virological suppression","volume":"606","author":"Sneller","year":"2022","journal-title":"Nature"},{"key":"B89","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1126\/science.aan8630","article-title":"Trispecific broadly neutralizing HIV antibodies mediate potent SHIV protection in macaques","volume":"358","author":"Xu","year":"2017","journal-title":"Science"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2024.09.043","article-title":"Adaptive multi-epitope targeting and avidity-enhanced nanobody platform for ultrapotent, durable antiviral therapy","volume":"187","author":"Xiang","year":"2024","journal-title":"Cell"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2024.1524356\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,14]],"date-time":"2025-01-14T00:12:21Z","timestamp":1736813541000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2024.1524356\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,14]]},"references-count":90,"alternative-id":["10.3389\/fimmu.2024.1524356"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2024.1524356","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,14]]},"article-number":"1524356"}}